XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 1,981.1 $ 2,026.0 $ 1,636.9
Cost of products sold 1,617.0 1,670.2 1,330.9
Gross profit 364.1 355.8 306.0
Selling and general expense 233.8 263.9 254.9
Research and development expense 23.0 21.2 18.8
Intangible asset amortization expense 62.9 61.0 53.4
Total nonmanufacturing expenses 319.7 346.1 327.1
Goodwill impairment expense 0.0 401.0 0.0
Restructuring and other impairment expense 38.1 22.6 19.1
Operating profit (loss) 6.3 (413.9) (40.2)
Interest expense 74.7 62.2 57.3
Loss on debt extinguishment 7.3 0.0 0.0
Other income (expense), net (3.2) (4.8) 1.0
Loss from continuing operations before income taxes (78.9) (480.9) (96.5)
Income tax expense (benefit) (30.2) 26.8 (27.6)
Net loss from continuing operations (48.7) (507.7) (68.9)
Income from discontinued operations, net of tax 0.0 198.2 62.3
Net loss $ (48.7) $ (309.5) $ (6.6)
Net income (loss) per share - basic:      
Loss per share from continuing operations (in dollars per share) $ (0.90) $ (9.33) $ (1.64)
Income per share from discontinued operations (in dollars per share) 0 3.64 1.46
Basic (in dollars per share) (0.90) (5.69) (0.18)
Net income (loss) per share – diluted:      
Loss per share from continuing operations (in dollars per share) (0.90) (9.33) (1.64)
Income per share from discontinued operations (in dollars per share) 0 3.64 1.46
Diluted (in dollars per share) $ (0.90) $ (5.69) $ (0.18)
Weighted average shares outstanding:      
Basic (in shares) 54,313,300 54,506,900 42,442,200
Diluted (in shares) 54,313,300 54,506,900 42,442,200